What is the recommended management of acute otitis media and chronic suppurative otitis media, including first‑line oral β‑lactam therapy, alternative regimens for recent β‑lactam exposure or penicillin allergy, topical fluoroquinolone therapy for CSOM, pain control, treatment duration, follow‑up timing, and red‑flag criteria for immediate ENT referral?

Otitis Media Treatment

Acute Otitis Media (AOM) Management

Immediate Pain Control (All Patients)

Pain management must be addressed immediately in every patient with AOM, regardless of whether antibiotics are prescribed. 1

• Administer weight-based acetaminophen or ibuprofen promptly, which typically provides relief within 24 hours—well before antibiotics can have any effect 1
• Continue analgesics throughout the acute phase, as antibiotics provide no symptomatic benefit in the first 24 hours and approximately 30% of children still report pain after 3–7 days of antibiotic therapy 1

First-Line Antibiotic Selection

High-dose amoxicillin (80–90 mg/kg/day divided twice daily, maximum 2 g per dose) is the recommended first-line treatment for most patients with AOM. 1

• This dosing achieves middle ear fluid concentrations adequate to overcome penicillin-resistant Streptococcus pneumoniae (92% eradication), beta-lactamase-negative Haemophilus influenzae (84% eradication), and covers the three most common pathogens responsible for approximately 70% of cases 1, 2

When to Use Amoxicillin-Clavulanate Instead

Switch to amoxicillin-clavulanate (90 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate in two divided doses) as first-line therapy when: 1

• The patient received amoxicillin within the preceding 30 days
• Concurrent purulent conjunctivitis is present (suggesting H. influenzae infection)
• The patient attends daycare or lives in an area with high prevalence of beta-lactamase-producing organisms
• Recurrent AOM unresponsive to amoxicillin

Twice-daily dosing of amoxicillin-clavulanate results in significantly less diarrhea (10–13%) compared with three-times-daily dosing while providing equivalent clinical efficacy. 1

Penicillin Allergy Alternatives

For non-severe (non-IgE-mediated) penicillin allergy: 1

• Cefdinir 14 mg/kg/day once daily (preferred for convenience and tolerability)
• Cefuroxime 30 mg/kg/day divided twice daily
• Cefpodoxime 10 mg/kg/day divided twice daily
• Cross-reactivity between penicillins and second/third-generation cephalosporins is negligible (approximately 0.1%), making these agents safe for non-anaphylactic allergies 1

For true Type I (IgE-mediated) penicillin allergy with anaphylaxis: 3

• Macrolides (azithromycin, clarithromycin) are the only safe oral options, though they carry 20–25% bacterial failure rates due to pneumococcal resistance exceeding 40% 1, 3
• Do not use trimethoprim-sulfamethoxazole or erythromycin-sulfisoxazole due to substantial resistance (>50% for S. pneumoniae) 1, 3

Treatment Duration by Age and Severity

Children younger than 2 years: 10-day course regardless of severity 1

Children 2–5 years: 1

• 7-day course for mild-to-moderate AOM
• 10-day course for severe AOM (moderate-to-severe otalgia, otalgia ≥48 hours, or fever ≥39°C/102.2°F)

Children ≥6 years and adults: 1, 3

• 5–7 day course for mild-to-moderate AOM
• 10-day course for severe AOM

Observation Without Immediate Antibiotics (Selected Cases)

Observation is appropriate for: 1

• Children 6–23 months with non-severe unilateral AOM
• Children ≥24 months with non-severe AOM (unilateral or bilateral)
• Requires: reliable follow-up mechanism within 48–72 hours and immediate antibiotic initiation if symptoms worsen or fail to improve

Immediate antibiotics are mandatory for: 1

• All children <6 months
• Children 6–23 months with severe AOM or bilateral non-severe AOM
• Adults with severe symptoms
• Any patient when reliable follow-up cannot be ensured

Management of Treatment Failure

Reassess at 48–72 hours if symptoms worsen or fail to improve. 1

Treatment escalation algorithm: 1

1. If initially observed: Start high-dose amoxicillin
2. If amoxicillin fails: Switch to amoxicillin-clavulanate (90 mg/kg/day)
3. If amoxicillin-clavulanate fails: Administer intramuscular ceftriaxone 50 mg/kg once daily for three consecutive days (superior to single-dose regimen)
4. After multiple failures: Consider tympanocentesis with culture and susceptibility testing, or use clindamycin with adjunctive coverage for H. influenzae and M. catarrhalis 1

The predominant pathogens in treatment failure are beta-lactamase-producing H. influenzae (62% eradication with amoxicillin) and M. catarrhalis. 2

Post-Treatment Expectations

Middle ear effusion persists in 60–70% of children at 2 weeks, 40% at 1 month, and 10–25% at 3 months after successful AOM treatment. 1

• This post-AOM effusion (otitis media with effusion, OME) requires monitoring but not antibiotics unless it persists >3 months with documented hearing loss 1
• Do not prescribe antibiotics for OME—they do not accelerate fluid clearance 1

---

Chronic Suppurative Otitis Media (CSOM) Management

Topical Fluoroquinolone Therapy

Topical fluoroquinolones (e.g., ofloxacin, ciprofloxacin-dexamethasone) are the treatment of choice for CSOM and tube otorrhea, not oral antibiotics. 1, 4

• Ofloxacin applied topically is as efficacious as oral amoxicillin-clavulanate for purulent otorrhea in patients with tympanostomy tubes 4
• Twice-daily dosing improves adherence and treatment efficacy 4
• The predominant pathogens in CSOM are Pseudomonas aeruginosa and Staphylococcus aureus, which require fluoroquinolone coverage 5, 4

Critical pitfall: Do not use ototoxic topical preparations (aminoglycosides) when tympanic membrane integrity is uncertain 6

---

Red-Flag Criteria for Immediate ENT Referral

Refer immediately for: 6

• Extension of infection outside the ear canal (mastoiditis, facial nerve involvement)
• Severe refractory symptoms despite appropriate antibiotic therapy
• Presence of granulation tissue (concern for malignant otitis externa or carcinoma)
• Immunocompromised patients with persistent symptoms
• Structural abnormalities or cholesteatoma
• Recurrent AOM (≥3 episodes in 6 months or ≥4 episodes in 12 months) requiring tympanostomy tube consideration 1

Note: Antibiotics do not prevent complications—33–81% of children who develop acute mastoiditis had received prior antibiotics 1

---

Common Pitfalls to Avoid

• Do not treat isolated tympanic membrane redness without middle ear effusion—this is not AOM and does not require antibiotics 1
• Do not confuse otitis externa with otitis media—persistent ear drainage with external ear erythema and swelling is otitis externa, not AOM treatment failure 1
• Do not use systemic antibiotics for tube otorrhea—topical fluoroquinolones are superior 1, 4
• Do not use macrolides or TMP-SMX as first-line therapy due to resistance rates exceeding 40–50% 1, 3
• Do not extend the duration of a failing antibiotic—switch to an agent with broader coverage instead 1